Jungwon Woo - Genexine Chief Officer
| 095700 Stock | KRW 5,840 210.00 3.47% |
Insider
Jungwon Woo is Chief Officer of Genexine
| Phone | 82 3 1628 3200 |
| Web | https://www.genexine.com |
Genexine Management Efficiency
The company has return on total asset (ROA) of (0.0172) % which means that it has lost $0.0172 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (10.0578) %, meaning that it generated substantial loss on money invested by shareholders. Genexine's management efficiency ratios could be used to measure how well Genexine manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Seok Kim | SillaJen | 39 | |
| Gyeong Gook | SillaJen | 53 | |
| Seungdo Lee | Woori Technology Investment | 58 | |
| Hyeok Gwon | SillaJen | 51 | |
| Junghoon Lee | Woori Technology Investment | 46 | |
| Sang Lee | ABL Bio | N/A | |
| Seong Chi | SillaJen | 67 | |
| You WeonKyoo | ABL Bio | N/A | |
| Jin Soo | AptaBio Therapeutics | N/A | |
| Hyeon Shin | SillaJen | 47 | |
| Changman Chae | Woori Technology Investment | N/A | |
| Jeong Noh | SillaJen | 66 | |
| Jaecheon Lee | ABL Bio | N/A | |
| KiJoo Lee | Woori Technology Investment | N/A | |
| Cheol Park | SillaJen | 52 | |
| Sang Joo | SillaJen | 54 | |
| Heungdae Woo | Woori Technology Investment | N/A | |
| Gyeong Hwang | SillaJen | 42 | |
| Jong Park | SillaJen | 58 | |
| Jung Kim | ABL Bio | N/A | |
| Jong Won | ABL Bio | N/A | |
Management Performance
| Return On Equity | -10.06 | |||
| Return On Asset | -0.0172 |
Genexine Leadership Team
Elected by the shareholders, the Genexine's board of directors comprises two types of representatives: Genexine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genexine. The board's role is to monitor Genexine's management team and ensure that shareholders' interests are well served. Genexine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genexine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| You Suh, Head Director | ||
| Jungwon Woo, Chief Officer | ||
| Sung CPA, CFO VP | ||
| Kyu Kim, Ex Bus | ||
| Jae Park, Ex Operation | ||
| Young Sung, Chairman Founder | ||
| JaiHyun Kwon, Director Transaction | ||
| Sung Lee, Head VP |
Genexine Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genexine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -10.06 | |||
| Return On Asset | -0.0172 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.41) % | |||
| Current Valuation | 2.14 T | |||
| Shares Outstanding | 20.55 M | |||
| Shares Owned By Insiders | 21.02 % | |||
| Shares Owned By Institutions | 7.17 % | |||
| Price To Sales | 10.84 X | |||
| Revenue | 36.83 B |
Pair Trading with Genexine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genexine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genexine will appreciate offsetting losses from the drop in the long position's value.Moving together with Genexine Stock
The ability to find closely correlated positions to Genexine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genexine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genexine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genexine to buy it.
The correlation of Genexine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genexine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genexine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genexine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Genexine Stock
Genexine financial ratios help investors to determine whether Genexine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genexine with respect to the benefits of owning Genexine security.